Put Options

3 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q4 2023

Feb 12, 2024

BUY
$75.49 - $124.16 $7,548 - $12,416
100 New
100 $12,000
Q4 2020

Feb 10, 2021

SELL
$78.0 - $104.5 $15,444 - $20,691
-198 Reduced 99.0%
2 $1,000
Q2 2020

Aug 10, 2020

BUY
$62.68 - $105.34 $12,536 - $21,068
200 New
200 $1,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $31.1B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track High Tower Advisors, LLC Portfolio

Follow High Tower Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Tower Advisors, LLC with notifications on news.